Krishna Yeshwant

Krishna Yeshwant is a declared insider of Verve Therapeutics, Inc. (board member), with filings sourced from SEC (Form 4). The record holds 6 filings, for trades running from 21 June 2021 to 25 July 2025.

The open-market record is one-sided, with 1 purchase worth €16.5M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

Most recently, on 28 July 2025, the filings show a transaction in Verve Therapeutics, Inc. The last purchase on record was published on 5 December 2023, which is 1,048 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.